AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,013,800 | -42.5% | 2,510,000 | 0.0% | 0.25% | -33.9% |
Q2 2023 | $27,835,900 | -27.8% | 2,510,000 | 0.0% | 0.38% | -33.8% |
Q1 2023 | $38,528,500 | -15.3% | 2,510,000 | +22.4% | 0.57% | -16.0% |
Q4 2022 | $45,489,500 | +92.1% | 2,050,000 | +41.4% | 0.68% | +55.6% |
Q3 2022 | $23,679,000 | +25.4% | 1,450,000 | +11.5% | 0.44% | +17.2% |
Q2 2022 | $18,889,000 | -21.3% | 1,300,000 | 0.0% | 0.37% | -14.8% |
Q1 2022 | $24,011,000 | -17.9% | 1,300,000 | +5.7% | 0.44% | -12.0% |
Q4 2021 | $29,237,000 | +3.2% | 1,230,000 | +7.0% | 0.50% | +11.9% |
Q3 2021 | $28,325,000 | +110.3% | 1,150,000 | +111.0% | 0.44% | +90.2% |
Q2 2021 | $13,467,000 | +13.3% | 545,000 | 0.0% | 0.23% | +14.1% |
Q1 2021 | $11,886,000 | -14.5% | 545,000 | 0.0% | 0.20% | -14.6% |
Q4 2020 | $13,908,000 | -9.3% | 545,000 | 0.0% | 0.24% | +10.1% |
Q3 2020 | $15,342,000 | -7.2% | 545,000 | -6.8% | 0.22% | -33.3% |
Q2 2020 | $16,532,000 | – | 585,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |